Guardian Pharmacy Services (GRDN) Asset Writedowns and Impairment (2023 - 2026)

Guardian Pharmacy Services' Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Asset Writedowns and Impairment rose 18.53% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.7 million (down 19.14% YoY), while the FY2025 annual figure was $4.6 million, down 28.08% from the prior year.
• Asset Writedowns and Impairment came in at $1.1 million for Q1 2026 at Guardian Pharmacy Services, down from $1.5 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $2.1 million in Q4 2024 to a low of $896000.0 in Q1 2025.
• A 4-year average of $1.3 million and a median of $1.3 million in 2023 frame the typical range for Asset Writedowns and Impairment.
• Across the five-year window, Asset Writedowns and Impairment jumped 56.27% in 2024 and plunged 42.0% in 2025, its largest moves.
• Guardian Pharmacy Services' Asset Writedowns and Impairment stood at $1.4 million in 2023, then surged by 56.27% to $2.1 million in 2024, then tumbled by 30.94% to $1.5 million in 2025, then dropped by 27.8% to $1.1 million in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $1.1 million, $1.5 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison